Fiala

Peptide library › Infections

Dalbavancin, oritavancin and telavancin

Also known as Dalvance, Orbactiv, Kimyrsa, Vibativ, Lipoglycopeptides

FDA-approved drugInfections

Long-acting hospital antibiotics related to vancomycin, used for serious skin infections including MRSA.

What people use it for

What Dalbavancin, oritavancin and telavancin does in the body

Glycopeptide antibiotics with a fatty tail. They block bacterial cell-wall building and, for some, damage the bacterial membrane. Dalbavancin and oritavancin last so long that one or two doses can replace days of treatment.

Strength of evidence

Strong: Phase 3 trials showed results similar to standard antibiotics.

Look up the evidence

Live searches of official databases. New to the terms? See the glossary.

Reported side effects & risks

Who should avoid it or take extra care

Not a complete list. Check with a doctor or pharmacist about your own health and medicines.

Regulatory status

FDA-approved: telavancin (2009), dalbavancin and oritavancin (2014). Hospital or clinic use.

How it's taken

Route: Drip into a vein; dalbavancin and oritavancin can be one or two doses

How long it lasts (half-life): Very long for dalbavancin (about 2 weeks) and oritavancin (about 10 days); about 8 hours for telavancin

Storage

Stored and prepared by the pharmacy or clinic, following the product label.

Latest research & news

Picked automatically from PubMed, ClinicalTrials.gov and the FDA, and updated daily. Early, lab and animal studies often don't carry over to people.

Keep track of Dalbavancin, oritavancin and telavancin privately

Fiala is a free app for logging doses, tracking vials and setting reminders. No account, and everything you log stays on your phone.

Open Dalbavancin, oritavancin and telavancin in Fiala How to install
Not medical advice. This page is general education. Talk to a qualified clinician before starting, stopping or changing any treatment.

More in Infections